Richard Bucala, MD, PhD (@bucalarichard) 's Twitter Profile
Richard Bucala, MD, PhD

@bucalarichard

Waldemar Von Zedtwitz Professor of Medicine and Professor of Pathology and of Epidemiology (Microbial Diseases); Chief, Rheumatology, Allergy & Immunology

ID: 1363259936814333952

linkhttps://medicine.yale.edu/intmed/raci/profile/richard_bucala/ calendar_today20-02-2021 22:51:18

28 Tweet

88 Followers

80 Following

Richard Bucala, MD, PhD (@bucalarichard) 's Twitter Profile Photo

First vaccine to fully immunize against malaria builds on pandemic-driven RNA tech academictimes.com/first-vaccine-… via @academictimes

ACR_Journals (@acr_journals) 's Twitter Profile Photo

Editor's Pick from the March 2021 Arthritis & Rheumatology: Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry by Milena Gianfrancesco, PhD MPH The COVID-19 Global Rheumatology Alliance onlinelibrary.wiley.com/doi/full/10.10…

Editor's Pick from the March 2021 Arthritis & Rheumatology:

Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry by <a href="/MilenaGianfran/">Milena Gianfrancesco, PhD MPH</a> <a href="/rheum_covid/">The COVID-19 Global Rheumatology Alliance</a>

onlinelibrary.wiley.com/doi/full/10.10…
American College of Rheumatology (@acrheum) 's Twitter Profile Photo

The ACR recently released #COVID19 #vaccine guidance & has submitted letters to state leaders urging them to prioritize patients on immunosuppressants in accordance with ACR recommendations. Help us amplify our message → acr.tw/3t1dIV6

The ACR recently released #COVID19 #vaccine guidance &amp; has submitted letters to state leaders urging them to prioritize patients on immunosuppressants in accordance with ACR recommendations. Help us amplify our message → acr.tw/3t1dIV6